NYSE:MCK - McKesson Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$136.59 +0.61 (+0.45 %)
(As of 07/15/2018 04:00 PM ET)
Previous Close$136.59
Today's Range$135.45 - $137.49
52-Week Range$131.43 - $178.86
Volume814,616 shs
Average Volume1.57 million shs
Market Capitalization$27.56 billion
P/E Ratio10.82
Dividend Yield1.00%
Beta1.29
McKesson logoMcKesson Corporation provides pharmaceuticals and medical supplies in the United States and internationally. It operates in three segments: U.S. Pharmaceutical and Specialty Solutions, European Pharmaceutical Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs, as well as other healthcare-related products; and offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices. It also provides specialty pharmaceutical solutions for pharmaceutical manufacturers; and medical-surgical supply distribution, logistics, and other services to healthcare providers. In addition, the company operates retail pharmacy chains in Europe and Canada, as well as supports independent pharmacy networks within North America and Europe; and supplies integrated pharmacy management systems, automated dispensing systems, and related services to retail, outpatient, central fill, specialty, and mail order pharmacies. Further, it provides software and analytics, network solutions, and technology-enabled services. The company serves retail national accounts, including national and regional chains, food and drug combinations, mail order pharmacies, and mass merchandisers; independent retail pharmacies; and institutional healthcare providers, such as hospitals, health systems, integrated delivery networks, and long-term care providers, as well as pharmaceutical manufacturers. McKesson Corporation was founded in 1833 and is headquartered in San Francisco, California.

Receive MCK News and Ratings via Email

Sign-up to receive the latest news and ratings for MCK and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NYSE
Industry Drugs, proprietaries, & sundries
Sub-IndustryHealth Care Distributors
SectorMedical
SymbolNYSE:MCK
CUSIP58155Q10
Phone415-983-8300

Debt

Debt-to-Equity Ratio0.67
Current Ratio1.01
Quick Ratio0.57

Price-To-Earnings

Trailing P/E Ratio10.82
Forward P/E Ratio10.22
P/E Growth1.27

Sales & Book Value

Annual Sales$208.36 billion
Price / Sales0.13
Cash Flow$28.1629 per share
Price / Cash4.85
Book Value$48.74 per share
Price / Book2.80

Profitability

EPS (Most Recent Fiscal Year)$12.62
Net Income$67 million
Net Margins0.03%
Return on Equity23.55%
Return on Assets4.23%

Miscellaneous

Employees78,000
Outstanding Shares201,780,000
Market Cap$27,560.58

The Truth About Cryptocurrencies

McKesson (NYSE:MCK) Frequently Asked Questions

What is McKesson's stock symbol?

McKesson trades on the New York Stock Exchange (NYSE) under the ticker symbol "MCK."

How often does McKesson pay dividends? What is the dividend yield for McKesson?

McKesson declared a quarterly dividend on Thursday, April 26th. Shareholders of record on Friday, June 1st will be given a dividend of $0.34 per share on Monday, July 2nd. This represents a $1.36 annualized dividend and a dividend yield of 1.00%. The ex-dividend date is Thursday, May 31st. View McKesson's Dividend History.

How will McKesson's stock buyback program work?

McKesson announced that its Board of Directors has initiated a stock repurchase plan on Thursday, October 27th 2016, which allows the company to repurchase $4,000,000,000.00 in shares, according to EventVestor. This repurchase authorization allows the company to repurchase up to 114% of its stock through open market purchases. Stock repurchase plans are typically an indication that the company's board believes its shares are undervalued.

How were McKesson's earnings last quarter?

McKesson Co. (NYSE:MCK) released its earnings results on Thursday, May, 24th. The company reported $3.49 EPS for the quarter, missing analysts' consensus estimates of $3.56 by $0.07. The firm earned $51.63 billion during the quarter, compared to analysts' expectations of $51.36 billion. McKesson had a return on equity of 23.55% and a net margin of 0.03%. McKesson's revenue for the quarter was up 6.0% on a year-over-year basis. During the same quarter in the previous year, the business earned $3.41 earnings per share. View McKesson's Earnings History.

When is McKesson's next earnings date?

McKesson is scheduled to release their next quarterly earnings announcement on Thursday, July, 26th 2018. View Earnings Estimates for McKesson.

What guidance has McKesson issued on next quarter's earnings?

McKesson updated its FY19 earnings guidance on Thursday, June, 28th. The company provided EPS guidance of $13.00-13.80 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $13.34. McKesson also updated its Q1 guidance to $2.85-2.95 EPS.

What price target have analysts set for MCK?

14 brokerages have issued 1 year price targets for McKesson's stock. Their forecasts range from $130.00 to $205.00. On average, they expect McKesson's share price to reach $171.8462 in the next twelve months. This suggests a possible upside of 25.8% from the stock's current price. View Analyst Ratings for McKesson.

What is the consensus analysts' recommendation for McKesson?

14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for McKesson in the last year. There are currently 1 sell rating, 5 hold ratings and 8 buy ratings for the stock, resulting in a consensus recommendation of "Buy."

Who are some of McKesson's key competitors?

Who are McKesson's key executives?

McKesson's management team includes the folowing people:
  • Mr. John H. Hammergren, Chairman, CEO & Pres (Age 59)
  • Britt J. Vitalone, CFO & Exec. VP (Age 49)
  • Ms. Lori A. Schechter, Chief Compliance Officer, Exec. VP & Gen. Counsel (Age 56)
  • Mr. Jorge L. Figueredo, Exec. VP of HR (Age 57)
  • Mr. Paul C. Julian, Exec. VP (Age 63)

Has McKesson been receiving favorable news coverage?

Media stories about MCK stock have been trending somewhat positive recently, Accern Sentiment Analysis reports. Accern identifies negative and positive media coverage by monitoring more than twenty million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. McKesson earned a coverage optimism score of 0.07 on Accern's scale. They also assigned news headlines about the company an impact score of 47.53 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock's share price in the near future.

Who are McKesson's major shareholders?

McKesson's stock is owned by many different of institutional and retail investors. Top institutional investors include Swedbank (0.31%), Hexavest Inc. (0.20%), Rockland Trust Co. (0.03%), Fjarde AP Fonden Fourth Swedish National Pension Fund (0.03%), Founders Capital Management LLC (0.03%) and Clinton Group Inc. (0.02%). Company insiders that own McKesson stock include Erin M Lampert, John H Hammergren, Lori A Schechter, M Christine Jacobs, Marie L/Ca Knowles, Susan R Salka and Wayne A Budd. View Institutional Ownership Trends for McKesson.

Which institutional investors are selling McKesson stock?

MCK stock was sold by a variety of institutional investors in the last quarter, including Investment House LLC, Acropolis Investment Management LLC, NN Investment Partners Holdings N.V., Atria Investments LLC, American National Bank, Trust Department MB Financial Bank N A, Gateway Investment Advisers LLC and Park National Corp OH. Company insiders that have sold McKesson company stock in the last year include Erin M Lampert, John H Hammergren, M Christine Jacobs and Marie L/Ca Knowles. View Insider Buying and Selling for McKesson.

Which institutional investors are buying McKesson stock?

MCK stock was bought by a variety of institutional investors in the last quarter, including Clinton Group Inc., Founders Capital Management LLC, Swedbank, State of Alaska Department of Revenue, DnB Asset Management AS, IFM Investors Pty Ltd, Campbell & CO Investment Adviser LLC and Rockland Trust Co.. Company insiders that have bought McKesson stock in the last two years include Lori A Schechter and Susan R Salka. View Insider Buying and Selling for McKesson.

How do I buy shares of McKesson?

Shares of MCK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is McKesson's stock price today?

One share of MCK stock can currently be purchased for approximately $136.59.

How big of a company is McKesson?

McKesson has a market capitalization of $27.56 billion and generates $208.36 billion in revenue each year. The company earns $67 million in net income (profit) each year or $12.62 on an earnings per share basis. McKesson employs 78,000 workers across the globe.

How can I contact McKesson?

McKesson's mailing address is ONE POST ST, SAN FRANCISCO CA, 94104. The company can be reached via phone at 415-983-8300 or via email at [email protected]


MarketBeat Community Rating for McKesson (NYSE MCK)

Community Ranking:  3.3 out of 5 (star star star)
Outperform Votes:  729 (Vote Outperform)
Underperform Votes:  371 (Vote Underperform)
Total Votes:  1,100
MarketBeat's community ratings are surveys of what our community members think about McKesson and other stocks. Vote "Outperform" if you believe MCK will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MCK will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 7/15/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.